AUROBINDO PHARMA LTD vs LUPIN LIMITED
A side-by-side comparison of AUROBINDO PHARMA LTD (AUROPHARMA) and LUPIN LIMITED (LUPIN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, LUPIN LIMITED leads AUROPHARMA vs LUPIN on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation13
- Profitability04
- Growth02
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
LUPIN takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
LUPIN takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
LUPIN takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
AUROPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + []
- − ["The company has delivered a poor sales growth of 6.3% over past five years.", "The company has delivered a poor profit growth of -8.1% over past five years."]
- + ["Company has delivered good profit growth of 34.3% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.8%"]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.